Makes soft tissue repair and bone fusion products for surgical use.
Jun 2026Revenue $110M/yrExpenses $101M/yr
No trend
Figures by year
Is Sanara MedTech profitable?
Yes. In the 12 months to Jun 2026, revenue was $110M and expenses $101M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $103M | $95.8M | $7.30M |
| Dec 2024 | $86.7M | $85.4M | $1.26M |
| Dec 2023 | $65.0M | $69.2M | −$4.22M |
| Dec 2022 | $45.8M | $58.4M | −$12.5M |
| Dec 2021 | $24.1M | $31.5M | −$7.38M |
| Dec 2020 | $15.6M | $20.6M | −$5.03M |
| Dec 2019 | $11.8M | $14.5M | −$2.74M |
| Dec 2018 | $5.84M | $6.34M | −$502K |
| Dec 2017 | $6.30M | $6.18M | $120K |
| Dec 2016 | $5.51M | $5.78M | −$272K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.